scholarly article | Q13442814 |
P50 | author | Kenneth Kendler | Q6390313 |
Xiangning Chen | Q67446541 | ||
Dermot Walsh | Q113000839 | ||
P2093 | author name string | Qi Chen | |
Xu Wang | |||
Francis A O'Neill | |||
P2860 | cites work | Characterization of PKCI and comparative studies with FHIT, related members of the HIT protein family | Q22003944 |
Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia | Q24306904 | ||
A note on exact tests of Hardy-Weinberg equilibrium | Q24531633 | ||
Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia | Q24532517 | ||
Domain-wide regulation of gene expression in the human genome | Q24676961 | ||
Statistical significance for genomewide studies | Q24681264 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
The structure of haplotype blocks in the human genome | Q27860500 | ||
Haploview: analysis and visualization of LD and haplotype maps | Q27860955 | ||
Reduction of nucleoside diphosphate kinase B, Rab GDP-dissociation inhibitor beta and histidine triad nucleotide-binding protein in fetal Down syndrome brain | Q28214304 | ||
Molecular genetic studies of schizophrenia | Q28242041 | ||
Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4) | Q28253496 | ||
Haplotypes spanning SPEC2, PDZ-GEF2 and ACSL6 genes are associated with schizophrenia | Q28267685 | ||
Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population | Q29614401 | ||
Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells. | Q30157975 | ||
Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data | Q31151241 | ||
Association study of CSF2RB with schizophrenia in Irish family and case - control samples | Q33668594 | ||
A test for linkage and association in general pedigrees: the pedigree disequilibrium test | Q34141820 | ||
Sex-specific association between bipolar affective disorder in women and GPR50, an X-linked orphan G protein-coupled receptor | Q34353797 | ||
The histidine triad protein Hint1 interacts with Pontin and Reptin and inhibits TCF-beta-catenin-mediated transcription | Q34433483 | ||
Why sex matters for neuroscience | Q34524235 | ||
Estrogen and cytokines production - the possible cause of gender differences in neurological diseases. | Q36074614 | ||
Association between the neuregulin 1 gene and schizophrenia: a systematic review | Q36219044 | ||
Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? | Q36258629 | ||
An update on the genetics of schizophrenia | Q36448169 | ||
Transcription and chromatin organization of a housekeeping gene cluster containing an integrated beta-globin locus control region | Q36491900 | ||
Making connections: boundaries and insulators in Drosophila | Q36955157 | ||
A highly significant association between a COMT haplotype and schizophrenia. | Q37203703 | ||
Gene expression of metabolic enzymes and a protease inhibitor in the prefrontal cortex are decreased in schizophrenia | Q38340511 | ||
Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study | Q38362304 | ||
The role of gender differences in the reduction of etiologic heterogeneity in schizophrenia | Q40834511 | ||
Support for a possible schizophrenia vulnerability locus in region 5q22-31 in Irish families | Q44618632 | ||
Clinical features of schizophrenia and linkage to chromosomes 5q, 6p, 8p, and 10p in the Irish Study of High-Density Schizophrenia Families | Q44869167 | ||
Genome-wide scans of three independent sets of 90 Irish multiplex schizophrenia families and follow-up of selected regions in all families provides evidence for multiple susceptibility genes | Q44889063 | ||
FP-TDI SNP scoring by manual and statistical procedures: a study of error rates and types | Q44892987 | ||
Interleukin 3 and schizophrenia: the impact of sex and family history | Q44925637 | ||
Supersensitivity to amphetamine in protein kinase-C interacting protein/HINT1 knockout mice | Q48319544 | ||
Gender-specific association of insertion/deletion polymorphisms in the nogo gene and chronic schizophrenia | Q48856990 | ||
Pedigree disequilibrium tests for multilocus haplotypes. | Q52010978 | ||
Implementing a unified approach to family-based tests of association. | Q52072093 | ||
Probing long-distance regulatory interactions in the Drosophila melanogaster bithorax complex using Dam identification. | Q52669864 | ||
A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6 | Q59791687 | ||
Evidence suggestive of a locus on chromosome 5q31 contributing to susceptibility for schizophrenia in German and Israeli families by multipoint affected sib-pair linkage analysis | Q73230984 | ||
Allelic discrimination using fluorogenic probes and the 5' nuclease assay | Q74618454 | ||
P433 | issue | 2-3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 200-207 | |
P577 | publication date | 2008-09-16 | |
P1433 | published in | Schizophrenia Research | Q7431607 |
P1476 | title | Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia? | |
P478 | volume | 106 |
Q27671245 | A new crystal form of human histidine triad nucleotide-binding protein 1 (hHINT1) in complex with adenosine 5′-monophosphate at 1.38 Å resolution |
Q44977420 | Acute behavioral effects of nicotine in male and female HINT1 knockout mice |
Q33498943 | Apoptotic engulfment pathway and schizophrenia |
Q33816462 | Association of the histidine-triad nucleotide-binding protein-1 (HINT1) gene variants with nicotine dependence |
Q30239953 | Axonal neuropathy with neuromyotonia: there is a HINT. |
Q42872711 | Cannabinoid receptors couple to NMDA receptors to reduce the production of NO and the mobilization of zinc induced by glutamate. |
Q36189837 | Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. |
Q48874499 | Differential expression of HINT1 in schizophrenia brain tissue |
Q42517534 | Effects of Hint1 deficiency on emotional-like behaviors in mice under chronic immobilization stress. |
Q42317501 | Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction |
Q43105205 | Expression, purification, crystallization and preliminary X-ray crystallographic analysis of human histidine triad nucleotide-binding protein 2 (hHINT2). |
Q34820601 | Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers |
Q47204896 | HINT1 in Neuropsychiatric Diseases: A Potential Neuroplastic Mediator |
Q36948351 | Hint1 gene deficiency enhances the supraspinal nociceptive sensitivity in mice. |
Q28506405 | Histidine triad nucleotide-binding protein 1 (HINT1) regulates Ca(2+) signaling in mouse fibroblasts and neuronal cells via store-operated Ca(2+) entry pathway |
Q33927060 | Identification of novel schizophrenia loci by homozygosity mapping using DNA microarray analysis |
Q41572995 | Interactions between the Kynurenine and the Endocannabinoid System with Special Emphasis on Migraine |
Q41912346 | Kinetic mechanism of human histidine triad nucleotide binding protein 1. |
Q38432031 | Post-translational modification of HINT1 mediates activation of MITF transcriptional activity in human melanoma cells. |
Q90662958 | Second messenger Ap4A polymerizes target protein HINT1 to transduce signals in FcεRI-activated mast cells |
Q38153348 | Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects |
Q42701910 | Social isolation induces schizophrenia-like behavior potentially associated with HINT1, NMDA receptor 1, and dopamine receptor 2. |
Q38262682 | The ON:OFF switch, σ1R-HINT1 protein, controls GPCR-NMDA receptor cross-regulation: implications in neurological disorders |
Q51750311 | The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases. |
Q34659000 | The cannabinoid receptor 1 associates with NMDA receptors to produce glutamatergic hypofunction: implications in psychosis and schizophrenia. |